Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05940688 · ClinicalTrials.gov registry record · NA

Providing an Optimized and emPowered Pregnancy for You (PᵌOPPY) Feasibility Study

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT05940688: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT05940688 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05940688, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The P3OPPY Project is one of five projects within the American Heart Association P3 EQUATE Network. The overarching goal of the P3 EQUATE American Heart Association Health Equity Research Network (HERN) is to promote equity in Maternal and Infant Health outcomes by identifying innovative and cost-effective strategies to enhance access to quality health information, care, and experiences during pregnancy, postnatal and postpartum/preconception periods, particularly for Black and under-served populations. Collectively, the investigators will collaborate with pregnant and postpartum individuals and their families, hospitals, and communities to discover ways to reduce racism and social problems that contribute to poor health outcomes.

Primary Outcome

Participant acceptance is defined as a yes response to this question: "I would recommend the care I received to someone in a similar situation."

Interventions

  • BEHAVIORAL Community Health Worker
  • BEHAVIORAL Digital Health intervention
  • BEHAVIORAL Digital Health Intervention plus Community Health Worker

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-07-17
Est. Completion 2024-07-01
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT05940688 record still lists

NCT05940688 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 3 interventions - of which Community Health Worker is the first listed.

NCT05940688 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05940688 about?

NCT05940688 is a clinical study titled "Providing an Optimized and emPowered Pregnancy for You (PᵌOPPY) Feasibility Study". The P3OPPY Project is one of five projects within the American Heart Association P3 EQUATE Network. The overarching goal of the P3 EQUATE American Heart Association Health Equity Research Network (HERN) is to promote equity in Maternal and Infant Health outcomes by identifying innovative and cost-ef...

What is the current status of trial NCT05940688?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-07-17. Estimated completion is 2024-07-01.

What interventions are being tested in trial NCT05940688?

The interventions under investigation include: Community Health Worker (BEHAVIORAL), Digital Health intervention (BEHAVIORAL), Digital Health Intervention plus Community Health Worker (BEHAVIORAL).

Who is sponsoring clinical trial NCT05940688?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05940688's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05940688, the US trial registry maintained by the National Library of Medicine. NCT05940688 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.